Search Results - "OLBRICHT, S"

Academic dermatology leadership in the United States -- Addressing the gender gap by Nambudiri, V.E., Shi, C.R., Vleugels, R.A., Olbricht, S.M.

Get full text

HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer by Konecny, Gottfried E., Thomssen, Christoph, Lück, Hans Joachim, Untch, Michael, Wang, He-Jing, Kuhn, Walter, Eidtmann, Holger, Bois, Andreas du, Olbricht, Sigrid, Steinfeld, Dieter, Möbus, Volker, Minckwitz, Gunter von, Dandekar, Suganda, Ramos, Lillian, Pauletti, Giovanni, Pegram, Mark D., Jänicke, Fritz, Slamon, Dennis J.

“…Background: HER-2/neu overexpressionappears to be associated with improved response to anthracycline-based chemotherapy, but its association with response to…”
Get full text

Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer by DU BOIS, A, MEIER, W, RICHTER, B, WAGNER, U, LÜCK, H. J, EMONS, G, MOEBUS, V, SCHROEDER, W, COSTA, S, BAUKNECHT, T, OLBRICHT, S, JACKISCH, C

“…The majority of patients with ovarian cancer are not cured by first-line treatment. Until now, no study could demonstrate any substantial benefit when exposing…”
Get full text

A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC–IV (AGO-OVAR protocol OVAR-8) by du Bois, A., Belau, A., Wagner, U., Pfisterer, J., Schmalfeldt, B., Richter, B., Staehle, A., Jackisch, C., Lueck, H.J., Schroeder, W., Burges, A., Olbricht, S., Elser, G.

“…A multicenter, nonrandomized, phase II study was initiated to evaluate the tolerability, toxicity, and activity of paclitaxel, carboplatin, and gemcitabine…”
Get full text

Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions by Brown, LF, Olbricht, SM, Berse, B, Jackman, RW, Matsueda, G, Tognazzi, KA, Manseau, EJ, Dvorak, HF, Van de Water, L

“…Delayed hypersensitivity (DH) is a T cell-mediated form of immune response characterized by a predominantly perivascular, mononuclear cell infiltrate. The…”
Get full text

LB1074 Predicting treatment decisions in elderly patients with non-melanoma skin cancers by Basu, P., Beckles, A., Porter, M.L., Olbricht, S.

Get full text

543 Evaluating the burden of prior authorization in the treatment of psoriasis by Popatia, S., Kimball, A., Olbricht, S., Porter, M.

Get full text

Dermatofibrosarcoma protuberans (DFSP): growth characteristics based on tumor modeling and a review of cases treated with Mohs micrographic surgery by Haycox, C L, Odland, P B, Olbricht, S M, Casey, B

“…Dermatofibrosarcoma protuberans (DFSP) is a relatively rare cutaneous tumor that is clinically challenging since it is locally highly invasive and aggressive,…”
Get more information

Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment by Haycox, Claire L., Odland, Peter B., Olbricht, Suzanne M., Piepkorn, Michael

“…Dermatofibrosarcoma protuberans (DFSP) is a rare, clinically challenging, soft tissue tumor. The main histologic differential of DFSP is usually a…”
Get full text

Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group by du Bois, A, Lück, H J, Meier, W, Möbus, V, Costa, S, Richter, B, Warm, M, Bauknecht, T, Schröder, W, Olbricht, S, Nitz, U, Jackisch, C

“…Since publication of the results of the Gynecologic Oncology Group III study, the combination of cisplatin/paclitaxel (Taxol; Bristol-Myers Squibb Company,…”
Get more information

Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study by Köhler, U, Olbricht, S S, Fuechsel, G, Kettner, E, Richter, B, Ridwelski, K

“…Phase I/II trials have shown that combination of an anthracycline with paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) represents a…”
Get more information

Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta by Varga, FJ, Vonderheid, EC, Olbricht, SM, Kadin, ME

“…Lymphomatoid papulosis (LyP) and pityriasis lichenoides et varioliformis acuta (PLEVA) are benign self-healing cutaneous eruptions that may be clinically and…”
Get full text

Treatment of malignant cutaneous tumors by Olbricht, S M

“…Malignant cutaneous tumors, consisting primarily of basal cell carcinoma, squamous cell carcinoma, and melanoma, are exceedingly common. Diagnosis is made by…”
Get more information

A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer by du Bois, Andreas, Lück, Hans-Joachim, Meier, Werner, Adams, Hans-Peter, Möbus, Volker, Costa, Serban, Bauknecht, Thomas, Richter, Barbara, Warm, Matthias, Schröder, Willibald, Olbricht, Sigrid, Nitz, Ulrike, Jackisch, Christian, Emons, Günther, Wagner, Uwe, Kuhn, Walther, Pfisterer, Jacobus

“…Background: Despite considerable improvement in the treatment of advanced ovarian cancer, the optimization of efficacy and tolerability remains an important…”
Get full text

Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies by SCHULZ, Solveig, SCHULZ, Stefan, SCHMITT, J, WIBORNY, D, SCHMIDT, H, OLBRICHT, S, WEISE, W, ROESSNER, A, GRAMSCH, C, HÖLLT, V

“…The long-acting somatostatin analogue octreotide (SMS 201-995) inhibits growth of certain breast cancer cell lines in vivo and in vitro. Because the…”
Get full text

Randomized Phase III Trial of Topotecan Following Carboplatin and Paclitaxel in First-line Treatment of Advanced Ovarian Cancer: A Gynecologic Cancer Intergroup Trial of the AGO-OVAR and GINECO by Pfisterer, Jacobus, Weber, Béatrice, Reuss, Alexander, Kimmig, Rainer, du Bois, Andreas, Wagner, Uwe, Bourgeois, Hugues, Meier, Werner, Costa, Serban, Blohmer, Jens-Uwe, Lortholary, Alain, Olbricht, Sigrid, Stähle, Anne, Jackisch, Christian, Hardy-Bessard, Anne-Claire, Möbus, Volker, Quaas, Jens, Richter, Barbara, Schröder, Willibald, Geay, Jean-François, Lück, Hans-Joachim, Kuhn, Walther, Meden, Harald, Nitz, Ulrike, Pujade-Lauraine, Eric

“…Background: The combination of carboplatin and paclitaxel is the standard of care for the treatment of ovarian cancer, yet rates of recurrence and death remain…”
Get full text

Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment by Haycox, Claire L., Odland, Peter B., Olbricht, Suzanne M., Piepkorn, Michael

“…Dermatofibrosarcoma protuberans (DFSP) is a rare, clinically challenging, soft tissue tumor. The main histologic differential of DFSP is usually a…”
Get full text

Clonal composition of T cells in lymphomatoid papulosis by Kadin, ME, Vonderheid, EC, Sako, D, Clayton, LK, Olbricht, S

“…A cDNA of the C beta 2 gene of the T-cell receptor was used as a probe to investigate the clonal composition of T cells in skin lesions of 5 patients with…”
Get full text

Periocular tumors by Salasche, S J, Shore, J W, Olbricht, S M

“…Next to the fear of death from cancer, patients fear loss of sight more than anything else. They are especially fearful of the potential for visual impairment…”
Get more information

Epithelial ovarian cancer: Therapy of early-stage disease by Meerpohl, H. G., Schröder, W., Olbricht, S.

Get full text